Description Module
The Description Module contains narrative descriptions of the clinical trial, including a brief summary and detailed description. These descriptions provide important information about the study's purpose, methodology, and key details in language accessible to both researchers and the general public.
Description Module path is as follows:
Study -> Protocol Section -> Description Module
Description Module
Ignite Creation Date:
2025-12-24 @ 10:48 PM
Ignite Modification Date:
2025-12-24 @ 10:48 PM
NCT ID:
NCT00368069
Brief Summary:
This is a safety and efficacy study of Keppra® extended release formulation - XR in patients with epilepsy.
Study:
NCT00368069
Study Brief:
Protocol Section:
NCT00368069